うさ研 founded in 2006
２０１０
２０１０年 |
|---|
| １．原著論文 1. Tetsuo Narumi, Ryoko Hayashi, Kenji Tomita, Kazuya Kobayashi, Noriko Tanahara, HiroakiOhno, Takeshi Naito, Eiichi Kodama, Masao Matsuoka, Shinya Oishi, and Nobutaka Fujii. Synthesisand Biological Evaluation of Selective CXCR4 Antagonists Containing Alkene Dipeptide Isosteres.Organic & Biomolecular Chemistry8:616-621, 2010 2. Kenji Watanabe, Shigeru Negi, Yukio Sugiura, Akiko Kiriyama, Akino Honbo, Katsumi Iga,Eiichi N. Kodama, Takeshi Naitoh, Masao Matsuoka, and Koji Kano. Binding of Multivalent AnionicPorphyrins to V3 Loop Fragments of HIV-1 gp120 and Their Antiviral Activity.Chemistry-An AsianJournal5:825 -834, 2010 3. Shenwei Li, Eiichi N Kodama, Yuuki Inoue, Hideki Tani, Yoshiharu Matsuura, Jing Zhang,Takashi Tanaka, Toshio Hattori. Procyanidin B-1 purified from Cinnamomi Cortex suppresses HCVreplication.Antiviral Chemistry and Chemotherapy20:239-248, 2010 4. Kazuki Izumi, Shota Nakamura, Hiroaki Nakano, Kazuya Shimura, Yasuko Sakagami, ShinyaOishi, Susumu Uchiyama, Tadayasu Ohkubo, Yuji Kobayashi, Nobutaka Fujii, Masao Matsuoka, EiichiN. Kodama. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41amino terminal heptad repeat.Antiviral Research87:179-186, 2010 5. Kazuki Shimane, Eiichi N. Kodama, Ikuhiko Nakase, Shiroh Futaki, Yasuteru Sakurai, YasukoSakagami, Xiaoguang Li, Toshio Hattori, Stefan G. Sarafianos, Masao Matsuoka. Rev-derivedpeptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.InternationalJournal of Biochemistry and Cell Biology42:1482-1488, 2010 6. Shinya Oishi, Kentaro Watanabe, Saori Ito, Michinori Tanaka, Hiroki Nishikawa, Hiroaki Ohno,Kazuki Shimane, Kazuki Izumi, Yasuko Sakagami, Eiichi N. Kodama, Masao Matsuoka, Akira Asaiand Nobutaka Fujii. Affinity selection and sequence-activity relationships of HIV-1 membrane fusioninhibitors directed at the drug-resistant variants.Medicinal Chemistry Communications1:276-281, 2010 7. Matthew Michael Schuckmann, Bruno Marchand, Atsuko Hachiya, Eiichi N. Kodama, Karen A.Kirby, Kamalendra Singh, Stefan G. Sarafianos. The N348I mutation at the connection subdomainof HIV-1 reverse transcriptase decreases binding to nevirapine.Journal of Biological Chemistry285:38700-38709, 2010 8. Kazuya Shimura, Daisuke Nameki, Keiko Kajiwara, Kentaro Watanabe, Yasuko Sakagami,Shinya Oishi, Nobutaka Fujii, Masao Matsuoka, Stefan G. Sarafianos, Eiichi N. Kodama. Resistanceprofiles of novel electrostatically constrained HIV-1 fusion inhibitors.Journal of BiologicalChemistry285:39471-39480, 2010 ２．総説 1. 児玉栄一 新規抗HIV薬の開発 特集・抗ウイルス薬物療法の現状と今後の展望 医薬ジャーナル 46:97-102, 2010 ３．学会発表と招待講演 1. Eiichi N. Kodama. Development of HIV-1 fusion inhibitors active to enfuvirtide resistantvariants. US-Japan Joint AIDS Panel: Resistance Meeting, Singapore, Dec 8-10, 2010 (招待講演) |
| |
